Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation

Cell Transplantation

Volumn 20, Issue 8, 2011, Pages 1221-1230

  Sattler, Christine ^a   Steinsdoerfer, Manuela ^a   Offers, Monika ^a   Fischer, Elke ^a   Schierl, Rudolf ^a   Heseler, Kathrin ^b   Däubener, Walter ^b   Seissler, Jochen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adenosine; CD39 CD73; Immunoregulation; Mesenchymal stromal cells (MSCs); T cell inhibition

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5' NUCLEOTIDASE; ADENOSINE; CD39 ANTIGEN;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOREGULATION; MESENCHYMAL STROMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; T LYMPHOCYTE;

MURINAE;

EID: 84930472274     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X546553     Document Type: Article

References (60)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30:42-48; 2002.
3. Baykov, A. A.; Evtushenko, O. A.; Avaeva, S. M. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal. Biochem. 171:266-270; 1988.
4. Beggs, K. J.; Lyubimov, A.; Borneman, J. N.; Bartholomew, A.; Moseley, A.; Dodds, R.; Archambault, M. P.; Smith, A. K.; McIntosh, K. R. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant. 15:711721; 2006.
5. Borsellino, G.; Kleinewietfeld, M.; Di Mitri, D.; Sternjak, A.; Diamantini, A.; Giometto, R.; Hopner, S.; Centonze, D.; Bernardi, G.; Dell'Acqua, M. L.; Rossini, P. M.; Battistini, L.; Rotzschke, O.; Falk, K. Expression of ecto- nucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232; 2007.
6. Bours, M. J.; Swennen, E. L.; Di Virgilio, F.; Cronstein, B. N.; Dagnelie, P. C. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112:358-404; 2006.
7. Cronstein, B. N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:5-13; 1994.
8. da Silva Meirelles, L.; Chagastelles, P. C.; Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119:2204-2213; 2006.
9. Daubener, W.; Wanagat, N.; Pilz, K.; Seghrouchni, S.; Fischer, H. G.; Hadding, U. A new, simple, bioassay for human IFN-gamma. J. Immunol. Methods 168:39-47; 1994.
10. Deaglio, S.; Dwyer, K. M.; Gao, W.; Friedman, D.; Usheva, A.; Erat, A.; Chen, J. F.; Enjyoji, K.; Linden, J.; Oukka, M.; Kuchroo, V. K.; Strom, T. B.; Robson, S. C. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204:1257-1265; 2007.
11. Denker, A. E.; Nicoll, S. B.; Tuan, R. S. Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1. Differentiation 59:25-34; 1995.
12. Digirolamo, C. M.; Stokes, D.; Colter, D.; Phinney, D. G.; Class, R.; Prockop, D. J. Propagation and senescence of human marrow stromal cells in culture: A simple colony- forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107: 275-281; 1999.
13. Ding, Y.; Bushell, A.; Wood, K. J. Mesenchymal stemcell immunosuppressive capabilities: Therapeutic implications in islet transplantation. Transplantation 89:270-273; 2010.
14. Ding, Y.; Xu, D.; Feng, G.; Bushell, A.; Muschel, R. J.; Wood, K. J. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 58: 1797-1806; 2009.
15. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843; 2002.
16. Djouad, F.; Plence, P.; Bony, C.; Tropel, P.; Apparailly, F.; Sany, J.; Noel, D.; Jorgensen, C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844; 2003.
17. Eltzschig, H. K.; Ibla, J. C.; Furuta, G. T.; Leonard, M. O.; Jacobson, K. A.; Enjyoji, K.; Robson, S. C.; Colgan, S. P. Coordinated adenine nucleotide phosphohy- drolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198:783-796; 2003.
18. English, K.; Barry, F. P.; Field-Corbett, C. P.; Mahon, B. P. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol. Lett. 110:91-100; 2007.
19. English, K.; Barry, F. P.; Mahon, B. P. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol. Lett. 115:50-58; 2008.
20. Erdmann, A. A.; Gao, Z. G.; Jung, U.; Foley, J.; Boren- stein, T.; Jacobson, K. A.; Fowler, D. H. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105:4707-4714; 2005.
21. Friedenstein, A. J.; Chailakhjan, R. K.; Lalykina, K. S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3:393-403; 1970.
22. Harris, S. G.; Padilla, J.; Koumas, L.; Ray, D.; Phipps, R. P. Prostaglandins as modulators of immunity. Trends Immunol. 23:144-150; 2002.
23. Hendricks, A.; Leibold, W.; Kaever, V.; Schuberth, H. J. Prostaglandin E2 is variably induced by bacterial superan-tigens in bovine mononuclear cells and has a regulatory role for the T cell proliferative response. Immunobiology 201:493-505; 2000.
24. Horwitz, E. M.; Prockop, D. J.; Fitzpatrick, L. A.; Koo, W. W.; Gordon, P. L.; Neel, M.; Sussman, M.; Orchard, P.; Marx, J. C.; Pyeritz, R. E.; Brenner, M. K. Transplant- ability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5:309-313; 1999.
25. Hoskin, D. W.; Mader, J. S.; Furlong, S. J.; Conrad, D. M.; Blay, J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (review). Int. J. Oncol. 32:527-535; 2008.
26. Imanishi, Y.; Saito, A.; Komoda, H.; Kitagawa-Sakakida, S.; Miyagawa, S.; Kondoh, H.; Ichikawa, H.; Sawa, Y. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J. Mol. Cell. Cardiol. 44:662-671; 2008.
27. Ishikane, S.; Ohnishi, S.; Yamahara, K.; Sada, M.; Harada, K.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Kitamura, S.; Nagaya, N.; Ikeda, T. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 26:2625-2633; 2008.
28. Kobie, J. J.; Shah, P. R.; Yang, L.; Rebhahn, J. A.; Fowell, D. J.; Mosmann, T. R. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J. Immunol. 177:6780-6786; 2006.
29. Koc, O. N.; Day, J.; Nieder, M.; Gerson, S. L.; Lazarus, H. M.; Krivit, W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30:215-222; 2002.
30. Krampera, M.; Cosmi, L.; Angeli, R.; Pasini, A.; Liotta, C.; Andreini, A.; Santarlasci, V.; Mazzinghi, B.; Pizzolo, D.; Vinante, F.; Romagnani, P.; Maggi, E.; Romagnani, S.; Annunziato, F. Role for interferon-gamma in the im-munomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398; 2006.
31. Krampera, M.; Glennie, S.; Dyson, J.; Scott, D.; Laylor, R.; Simpson, E.; Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729; 2003.
32. Krausgrill, B.; Vantler, M.; Burst, V.; Raths, M.; Halbach, M.; Frank, K.; Schynkowski, S.; Schenk, K.; Hescheler, J.; Rosenkranz, S.; Muller-Ehmsen, J. Influence of cell treatment with PDGF-BB and reperfusion on cardiac persistence of mononuclear and mesenchymal bone marrow cells after transplantation into acute myocardial infarction in rats. Cell Transplant. 18:847-853; 2009.
33. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685; 1970.
34. Lazarus, H. M.; Koc, O. N.; Devine, S. M.; Curtin, P.; Maziarz, R. T.; Holland, H. K.; Shpall, E. J.; McCarthy, P.; Atkinson, K.; Cooper, B. W.; Gerson, S. L.; Laughlin, M. J.; Loberiza, Jr., F. R.; Moseley, A. B.; Bacigalupo, C. Cotransplantation of HLA-identical sibling culture- expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11:389-398; 2005.
35. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:14391441; 2004.
36. Matsuda, R.; Yoshikawa, M.; Kimura, H.; Ouji, Y.; Nakase, H.; Nishimura, F.; Nonaka, J.; Toriumi, H.; Yamada, S.; Nishiofuku, M.; Moriya, K.; Ishizaka, S.; Nakamura, M.; Sakaki, T. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant. 18:39-54; 2009.
37. Mazo, M.; Gavira, J. J.; Abizanda, G.; Moreno, C.; Ecay, M.; Soriano, M.; Aranda, P.; Collantes, M.; Alegria, E.; Merino, J.; Penuelas, I.; Garcia Verdugo, J. M.; Pelacho, B.; Prosper, F. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant. 19:313-328; 2010.
38. Meisel, R.; Zibert, A.; Laryea, M.; Gobel, U.; Daubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:46194621; 2004.
39. Muller, C. E.; Iqbal, J.; Baqi, Y.; Zimmermann, H.; Rollich, A.; Stephan, H. Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg. Med. Chem. Lett. 16:5943-5947; 2006.
40. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
41. Nemeth, K.; Leelahavanichkul, A.; Yuen, P. S.; Mayer, B.; Parmelee, A.; Doi, K.; Robey, P. G.; Leelahavanich- kul, K.; Koller, B. H.; Brown, J. M.; Hu, X.; Jelinek, I.; Star, R. A.; Mezey, E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15:42-49; 2009.
42. Ohta, A.; Sitkovsky, M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and pro-tection from tissue damage. Nature 414:916-920; 2001.
43. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simo- netti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
44. Popp, F. C.; Eggenhofer, E.; Renner, P.; Slowik, P.; Lang, S. A.; Kaspar, H.; Geissler, E. K.; Piso, P.; Schlitt, H. J.; Dahlke, M. H. Mesenchymal stem cells can induce longterm acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl. Immunol. 20:55-60; 2008.
45. Rasmusson, I. Immune modulation by mesenchymal stem cells. Exp. Cell Res. 312:2169-2179; 2006.
46. Rasmusson, I.; Ringden, O.; Sundberg, B.; Le Blanc, K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. 305:33-41; 2005.
47. Sato, K.; Ozaki, K.; Oh, I.; Meguro, A.; Hatanaka, K.; Nagai, T.; Muroi, K.; Ozawa, K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228-234; 2007.
48. Snijdewint, F. G.; Kalinski, P.; Wierenga, E. A.; Bos, J. D.; Kapsenberg, M. L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:5321-5329; 1993.
49. Sun, S.; Guo, Z.; Xiao, X.; Liu, B.; Liu, X.; Tang, P. H.; Mao, N. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21:527535; 2003.
50. Thiel, M.; Caldwell, C. C.; Sitkovsky, M. V. The critical role of adenosine A2A receptors in downregulation of in-flammation and immunity in the pathogenesis of infectious diseases. Microbes Infect. 5:515-526; 2003.
51. Tisato, V.; Naresh, K.; Girdlestone, J.; Navarrete, C.; Dazzi, F. Mesenchymal stem cells of cord blood originare effective at preventing but not treating graft-versus- host disease. Leukemia 21:1992-1999; 2007.
52. Tropel, P.; Noel, D.; Platet, N.; Legrand, P.; Benabid, E. L.; Berger, F. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp. Cell Res. 295:395-406; 2004.
53. Tse, W. T.; Pendleton, J. D.; Beyer, W. M.; Egalka, M. C.; Guinan, E. C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75:389-397; 2003.
54. Wagner, W.; Horn, P.; Castoldi, M.; Diehlmann, A.; Bork, S.; Saffrich, R.; Benes, V.; Blake, J.; Pfister, S.; Eckstein, V.; Ho, A. D. Replicative senescence of mesenchymal stem cells: A continuous and organized process. PLoS One 3:e2213; 2008.
55. Wagner, W.; Wein, F.; Seckinger, A.; Frankhauser, M.; Wirkner, U.; Krause, U.; Blake, J.; Schwager, C.; Eckstein, V.; Ansorge, W.; Ho, A. D. Comparative char acteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 33:1402-1416; 2005.
56. Wall, M. J.; Wigmore, G.; Lopatar, J.; Frenguelli, B. G.; Dale, N. The novel NTPDase inhibitor sodium polyoxo- tungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition. Neuropharmacology 55: 1251-1258; 2008.
57. Wollert, K. C.; Meyer, G. P.; Lotz, J.; Ringes-Lichten- berg, S.; Lippolt, P.; Breidenbach, C.; Fichtner, S.; Korte, T.; Hornig, B.; Messinger, D.; Arseniev, L.; Hertenstein, F.; Ganser, A.; Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364: 141-148; 2004.
58. Wu, Y.; Sun, X.; Kaczmarek, E.; Dwyer, K. M.; Bianchi, E.; Usheva, A.; Robson, S. C. RanBPM associates with CD39 and modulates ecto-nucleotidase activity. Biochem. J. 396:23-30; 2006.
59. Xu, G.; Zhang, L.; Ren, G.; Yuan, Z.; Zhang, Y.; Zhao, R. C.; Shi, Y. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res. 17:240248; 2007.
60. Zimmermann, H. 5'-Nucleotidase: Molecular structure and functional aspects. Biochem. J. 285:345-365; 1992.